Lupin launches first chatbot for patients to know about their ailments

BENGALURU: Pharma major Lupin launched a chatbot named ‘ANYA’ designed to provide medically verified information for health-related queries. The disease awareness bot aims to answer patient queries related to ailments.

Launched at the 46th Annual Meeting of the Research Society for the Study of Diabetes, ANYA is chatbot trained to help patients with health-related concerns as part of their disease-management. As a start to digitize the patient journey in the overall healthcare space, Lupin is starting with ANYA to address queries related to diabetes.

“At Lupin, we continue to explore ways to integrate technology to support effective patient care. Chatbot as a technology has enormous potential to aid in medical assistance and to support in building awareness and breaking myths associated with various therapies. We are taking the first step to offer this AI-based chatbot for patients and health-givers and we believe this will be a game changer in the field of disease management in the future. This will also be a significant step in providing better access in rural markets as we adopt and launch digital healthcare platforms for better outreach.” said Rajeev Sibal, President – IRF, Lupin.

Recent research suggests that India is estimated to have had 72 million cases of diabetes in 2017 and the figure is expected to almost double to 134 million by 2025. Patients today are technologically advanced and are likely to be well informed on managing their health conditions. However, there is a lack of trusted and comprehensive sources on disease-management information for patients. The idea behind launching ANYA is to bridge this gap by providing medically verified information and acting as a preferred partner for doctors in resolving patient queries anytime, the company said in a release.

ANYA in Sanskrit means inexhaustible or limitless and this is the prime quality of the bot. As it evolves, ANYA will address all queries of patients and ensure their health conversations continue. ANYA is essentially a disease-management partner who aims to facilitate users in partnering with doctors in their journey to manage ailments. The main idea is to create a platform where patients can get easy and ready access to medically verified information, for their queries at any given time. ANYA will not replace Doctor’s diagnosis but rather act as a trusted information provider.

ANYA is currently hosted on Facebook Messenger and will connect with patients in three ways: Users can run a search for @askanyabot on Facebook Messenger and can start chatting, anyone visiting Lupin’s ShapingHealth Facebook page will automatically get a chat popup from ANYA, the bot will also have its own Facebook page and anyone visiting this page will automatically get a chat popup from ANYA.

  • Related Posts

    3-month relief: Final call for 10,000 pharmacists to renew registration

    At least 70,000 pharmacists are registered in Haryana; of these, about 10,000 — whose registrations expired on December 31, 2020, — have not yet renewed The Haryana State Pharmacy Council…

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Marksans Pharma Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of Benzonatate capsules indicated for treatment of persistent cough, bronchitis,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    3-month relief: Final call for 10,000 pharmacists to renew registration

    3-month relief: Final call for 10,000 pharmacists to renew registration

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Marksans Pharma gets USFDA nod for generic Benzonatate capsules

    Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

    Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

    Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

    Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices